Rani Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: RANI · Form: 8-K · Filed: May 29, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | 8-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Rani Therapeutics filed an 8-K on shareholder votes. Check for details on governance changes.
AI Summary
Rani Therapeutics Holdings, Inc. filed an 8-K on May 29, 2025, reporting on matters submitted to a vote of security holders as of May 28, 2025. The filing details the company's corporate actions and governance, as required by the Securities Exchange Act of 1934.
Why It Matters
This filing provides transparency to investors regarding important decisions made by Rani Therapeutics that require or have involved shareholder approval, impacting corporate governance.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding shareholder votes and does not indicate new financial or operational risks.
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of earliest event reported
- May 29, 2025 (date) — Date of Report
- Securities Exchange Act of 1934 (legal_document) — Governing regulation
FAQ
What specific matters were submitted to a vote of Rani Therapeutics' security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text excerpt. A full review of the 8-K document would be required to ascertain the exact proposals.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 28, 2025.
What is the principal executive office address for Rani Therapeutics Holdings, Inc.?
The principal executive office address for Rani Therapeutics Holdings, Inc. is 2051 Ringwood Avenue, San Jose, California 95131.
Under which section of the Securities Exchange Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Rani Therapeutics' state of incorporation?
Rani Therapeutics Holdings, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).